Department of Biomedical Imaging and Image-Guided Therapy, Medical University Vienna, Vienna, Austria.
Department of Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany.
Eur Radiol. 2023 Dec;33(12):9022-9037. doi: 10.1007/s00330-023-09915-3. Epub 2023 Jul 20.
PSC strictures are routinely diagnosed on T2-MRCP as dominant- (DS) or high-grade stricture (HGS). However, high inter-observer variability limits their utility. We introduce the "potential functional stricture" (PFS) on T1-weighted hepatobiliary-phase images of gadoxetic acid-enhanced MR cholangiography (T1-MRC) to assess inter-reader agreement on diagnosis, location, and prognostic value of PFS on T1-MRC vs. DS or HGS on T2-MRCP in PSC patients, using ERCP as the gold standard.
Six blinded readers independently reviewed 129 MRIs to diagnose and locate stricture, if present. DS/HGS was determined on T2-MRCP. On T1-MRC, PFS was diagnosed if no GA excretion was seen in the CBD, hilum or distal RHD, or LHD. If excretion was normal, "no functional stricture" (NFS) was diagnosed. T1-MRC diagnoses (NFS = 87; PFS = 42) were correlated with ERCP, clinical scores, labs, splenic volume, and clinical events. Statistical analyses included Kaplan-Meier curves and Cox regression.
Interobserver agreement was almost perfect for NFS vs. PFS diagnosis, but fair to moderate for DS and HGS. Forty-four ERCPs in 129 patients (34.1%) were performed, 39 in PFS (92.9%), and, due to clinical suspicion, five in NFS (5.7%) patients. PFS and NFS diagnoses had 100% PPV and 100% NPV, respectively. Labs and clinical scores were significantly worse for PFS vs. NFS. PFS patients underwent more diagnostic and therapeutic ERCPs, experienced more clinical events, and reached significantly more endpoints (p < 0.001) than those with NFS. Multivariate analysis identified PFS as an independent risk factor for liver-related events.
T1-MRC was superior to T2-MRCP for stricture diagnosis, stricture location, and prognostication.
Because half of PSC patients will develop clinically-relevant strictures over the course of the disease, earlier more confident diagnosis and correct localization of functional stricture on gadoxetic acid-enhanced MRI may optimize management and improve prognostication.
• There is no consensus regarding biliary stricture imaging features in PSC that have clinical relevance. • Twenty-minute T1-weighted MRC images correctly classified PSC patients with potential (PFS) vs with no functional stricture (NFS). • T1-MRC diagnoses may reduce the burden of diagnostic ERCPs.
PSC 狭窄通常在 T2-MRCP 上被诊断为优势(DS)或高级别狭窄(HGS)。然而,观察者间的高度变异性限制了它们的应用。我们在钆塞酸增强磁共振胰胆管造影(T1-MRC)的 T1 加权肝胆期图像上引入“潜在功能狭窄”(PFS),以评估 T1-MRC 上的 PFS 与 T2-MRCP 上的 DS 或 HGS 在 PSC 患者中的诊断、位置和预后价值,以 ERCP 为金标准。
六位盲法读者独立分析了 129 例 MRI,以诊断和定位狭窄(如果存在)。DS/HGS 在 T2-MRCP 上确定。在 T1-MRC 上,如果 CBD、肝门或远端 RHD 或 LHD 未见 GA 排泄,则诊断为 PFS。如果排泄正常,则诊断为“无功能狭窄”(NFS)。T1-MRC 诊断(NFS=87;PFS=42)与 ERCP、临床评分、实验室检查、脾脏体积和临床事件相关。统计分析包括 Kaplan-Meier 曲线和 Cox 回归。
NFS 与 PFS 诊断的观察者间一致性几乎是完美的,但 DS 和 HGS 的一致性是公平到中度的。在 129 例患者中进行了 44 例 ERCP(34.1%),其中 39 例在 PFS(92.9%)中进行,由于临床怀疑,5 例在 NFS(5.7%)患者中进行。PFS 和 NFS 诊断的 PPV 和 NPV 均为 100%。与 NFS 相比,PFS 的实验室和临床评分明显更差。与 NFS 相比,PFS 患者接受了更多的诊断和治疗性 ERCP,经历了更多的临床事件,并达到了更多的终点(p<0.001)。多变量分析确定 PFS 是肝相关事件的独立危险因素。
T1-MRC 优于 T2-MRCP 用于狭窄的诊断、狭窄的定位和预后。
由于一半的 PSC 患者在疾病过程中会出现具有临床意义的狭窄,因此更早、更有信心地诊断和正确定位功能狭窄可能会优化管理并改善预后。
• 目前对于 PSC 有临床意义的胆道狭窄影像学特征尚无共识。• 20 分钟的 T1 加权 MRC 图像正确分类了 PSC 患者的潜在(PFS)与无功能狭窄(NFS)。• T1-MRC 诊断可能减少诊断性 ERCP 的负担。